Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Jun 15;101(12):2821–2830. doi: 10.1172/JCI1068

Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia.

R Mallone 1, S Ferrua 1, M Morra 1, E Zocchi 1, K Mehta 1, L D Notarangelo 1, F Malavasi 1
PMCID: PMC508873  PMID: 9637716

Abstract

Studies on murine B lymphocytes showed that Bruton's tyrosine kinase mediates signal transduction induced via CD38, a nonlineage-restricted 45-kD ectoenzyme. This signaling is defective in B cells from X-linked immunodeficient mice affected with the analogue of human X-linked agammaglobulinemia (XLA). We performed a structural and functional analysis of CD38 in XLA and other immunodeficiencies, using EBV-immortalized B cells derived from such patients. Membrane CD38 was not significantly different from controls in structure, epitope density, enzymatic activity, and internalization upon binding of agonistic mAbs. Meanwhile, an increased release of soluble CD38 from XLA cells was observed: immunoprecipitation from XLA culture media yielded a protein of approximately 78 kD (p78), reacting also in Western blot and displaying both enzymatic activities and a peptide map similar to membrane CD38. Soluble forms and homotypic aggregations of CD38 were documented in different cell models and by crystallographic analysis of the Aplysia ADP-ribosyl cyclase, the ancestor of human CD38. p78 might represent the product of an altered turn-over of membrane CD38, a starting point for studying its association with Bruton's tyrosine kinase and its role in XLA and other B cell immunodeficiencies.

Full Text

The Full Text of this article is available as a PDF (316.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alessio M., Roggero S., Funaro A., De Monte L. B., Peruzzi L., Geuna M., Malavasi F. CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells. J Immunol. 1990 Aug 1;145(3):878–884. [PubMed] [Google Scholar]
  2. Berthelier V., Malavasi F., Bismuth G., Schmitt C., Deterre P. Report on the 2nd International CD38 workshop. Res Immunol. 1996 Jul-Aug;147(6):407–411. doi: 10.1016/0923-2494(96)82050-5. [DOI] [PubMed] [Google Scholar]
  3. Cesano A., Visonneau S., Deaglio S., Malavasi F., Santoli D. Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells. J Immunol. 1998 Feb 1;160(3):1106–1115. [PubMed] [Google Scholar]
  4. Conley M. E. B cells in patients with X-linked agammaglobulinemia. J Immunol. 1985 May;134(5):3070–3074. [PubMed] [Google Scholar]
  5. Conley M. E., Fitch-Hilgenberg M. E., Cleveland J. L., Parolini O., Rohrer J. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet. 1994 Oct;3(10):1751–1756. doi: 10.1093/hmg/3.10.1751. [DOI] [PubMed] [Google Scholar]
  6. Conley M. E., Parolini O., Rohrer J., Campana D. X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene. Immunol Rev. 1994 Apr;138:5–21. doi: 10.1111/j.1600-065x.1994.tb00844.x. [DOI] [PubMed] [Google Scholar]
  7. Conley M. E., Sweinberg S. K. Females with a disorder phenotypically identical to X-linked agammaglobulinemia. J Clin Immunol. 1992 Mar;12(2):139–143. doi: 10.1007/BF00918144. [DOI] [PubMed] [Google Scholar]
  8. Deaglio S., Dianzani U., Horenstein A. L., Fernández J. E., van Kooten C., Bragardo M., Funaro A., Garbarino G., Di Virgilio F., Banchereau J. Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells. J Immunol. 1996 Jan 15;156(2):727–734. [PubMed] [Google Scholar]
  9. Deaglio S., Morra M., Mallone R., Ausiello C. M., Prager E., Garbarino G., Dianzani U., Stockinger H., Malavasi F. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol. 1998 Jan 1;160(1):395–402. [PubMed] [Google Scholar]
  10. Deterre P., Gelman L., Gary-Gouy H., Arrieumerlou C., Berthelier V., Tixier J. M., Ktorza S., Goding J., Schmitt C., Bismuth G. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites. J Immunol. 1996 Aug 15;157(4):1381–1388. [PubMed] [Google Scholar]
  11. Dianzani U., Funaro A., DiFranco D., Garbarino G., Bragardo M., Redoglia V., Buonfiglio D., De Monte L. B., Pileri A., Malavasi F. Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol. 1994 Aug 1;153(3):952–959. [PubMed] [Google Scholar]
  12. Drach J., Zhao S., Malavasi F., Mehta K. Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid. Biochem Biophys Res Commun. 1993 Sep 15;195(2):545–550. doi: 10.1006/bbrc.1993.2080. [DOI] [PubMed] [Google Scholar]
  13. Ferrero E., Malavasi F. Human CD38, a leukocyte receptor and ectoenzyme, is a member of a novel eukaryotic gene family of nicotinamide adenine dinucleotide+-converting enzymes: extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP-ribosyl cyclase. J Immunol. 1997 Oct 15;159(8):3858–3865. [PubMed] [Google Scholar]
  14. Funaro A., De Monte L. B., Dianzani U., Forni M., Malavasi F. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol. 1993 Oct;23(10):2407–2411. doi: 10.1002/eji.1830231005. [DOI] [PubMed] [Google Scholar]
  15. Funaro A., Horenstein A. L., Calosso L., Morra M., Tarocco R. P., Franco L., De Flora A., Malavasi F. Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids. Int Immunol. 1996 Nov;8(11):1643–1650. doi: 10.1093/intimm/8.11.1643. [DOI] [PubMed] [Google Scholar]
  16. Funaro A., Reinis M., Trubiani O., Santi S., Di Primio R., Malavasi F. CD38 functions are regulated through an internalization step. J Immunol. 1998 Mar 1;160(5):2238–2247. [PubMed] [Google Scholar]
  17. Funaro A., Spagnoli G. C., Ausiello C. M., Alessio M., Roggero S., Delia D., Zaccolo M., Malavasi F. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol. 1990 Oct 15;145(8):2390–2396. [PubMed] [Google Scholar]
  18. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Galione A. Cyclic ADP-ribose: a new way to control calcium. Science. 1993 Jan 15;259(5093):325–326. doi: 10.1126/science.8380506. [DOI] [PubMed] [Google Scholar]
  20. Gearing A. J., Newman W. Circulating adhesion molecules in disease. Immunol Today. 1993 Oct;14(10):506–512. doi: 10.1016/0167-5699(93)90267-O. [DOI] [PubMed] [Google Scholar]
  21. Graeff R. M., Walseth T. F., Fryxell K., Branton W. D., Lee H. C. Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity. J Biol Chem. 1994 Dec 2;269(48):30260–30267. [PubMed] [Google Scholar]
  22. Guida L., Franco L., Zocchi E., De Flora A. Structural role of disulfide bridges in the cyclic ADP-ribose related bifunctional ectoenzyme CD38. FEBS Lett. 1995 Jul 24;368(3):481–484. doi: 10.1016/0014-5793(95)00715-l. [DOI] [PubMed] [Google Scholar]
  23. Hager D. A., Burgess R. R. Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes. Anal Biochem. 1980 Nov 15;109(1):76–86. doi: 10.1016/0003-2697(80)90013-5. [DOI] [PubMed] [Google Scholar]
  24. Hoffman T., Winchester R., Schulkind M., Frias J. L., Ayoub E. M., Good R. A. Hypoimmunoglobulinemia with normal T cell function in female siblings. Clin Immunol Immunopathol. 1977 May;7(3):364–371. doi: 10.1016/0090-1229(77)90070-8. [DOI] [PubMed] [Google Scholar]
  25. Hoshino S., Kukimoto I., Kontani K., Inoue S., Kanda Y., Malavasi F., Katada T. Mapping of the catalytic and epitopic sites of human CD38/NAD+ glycohydrolase to a functional domain in the carboxyl terminus. J Immunol. 1997 Jan 15;158(2):741–747. [PubMed] [Google Scholar]
  26. Howard M., Grimaldi J. C., Bazan J. F., Lund F. E., Santos-Argumedo L., Parkhouse R. M., Walseth T. F., Lee H. C. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science. 1993 Nov 12;262(5136):1056–1059. doi: 10.1126/science.8235624. [DOI] [PubMed] [Google Scholar]
  27. Hurwitz R., Hozier J., LeBien T., Minowada J., Gajl-Peczalska K., Kubonishi I., Kersey J. Characterization of a leukemic cell line of the pre-B phenotype. Int J Cancer. 1979 Feb;23(2):174–180. doi: 10.1002/ijc.2910230206. [DOI] [PubMed] [Google Scholar]
  28. Kansas G. S., Wood G. S., Tedder T. F. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol. 1991 Apr 1;146(7):2235–2244. [PubMed] [Google Scholar]
  29. Kikuchi Y., Yasue T., Miyake K., Kimoto M., Takatsu K. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11814–11818. doi: 10.1073/pnas.92.25.11814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kinnon C., Hinshelwood S., Levinsky R. J., Lovering R. C. X-linked agammaglobulinemia--gene cloning and future prospects. Immunol Today. 1993 Nov;14(11):554–558. doi: 10.1016/0167-5699(93)90187-P. [DOI] [PubMed] [Google Scholar]
  31. Kumagai M., Coustan-Smith E., Murray D. J., Silvennoinen O., Murti K. G., Evans W. E., Malavasi F., Campana D. Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med. 1995 Mar 1;181(3):1101–1110. doi: 10.1084/jem.181.3.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lee H. C., Zocchi E., Guida L., Franco L., Benatti U., De Flora A. Production and hydrolysis of cyclic ADP-ribose at the outer surface of human erythrocytes. Biochem Biophys Res Commun. 1993 Mar 15;191(2):639–645. doi: 10.1006/bbrc.1993.1265. [DOI] [PubMed] [Google Scholar]
  33. Lund F., Solvason N., Grimaldi J. C., Parkhouse R. M., Howard M. Murine CD38: an immunoregulatory ectoenzyme. Immunol Today. 1995 Oct;16(10):469–473. doi: 10.1016/0167-5699(95)80029-8. [DOI] [PubMed] [Google Scholar]
  34. Malavasi F., Caligaris-Cappio F., Milanese C., Dellabona P., Richiardi P., Carbonara A. O. Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum Immunol. 1984 Jan;9(1):9–20. doi: 10.1016/0198-8859(84)90003-x. [DOI] [PubMed] [Google Scholar]
  35. Malavasi F., Funaro A., Roggero S., Horenstein A., Calosso L., Mehta K. Human CD38: a glycoprotein in search of a function. Immunol Today. 1994 Mar;15(3):95–97. doi: 10.1016/0167-5699(94)90148-1. [DOI] [PubMed] [Google Scholar]
  36. Malavasi F., Milanese C., Fabbi M., Richiardi P., Caligaris-Cappio F., Ferrero E., Roggero S., Dellabona P., Ceppellini R. Generation and characterization of murine monoclonal antibodies against HLA Class II molecules. Diagn Immunol. 1984;2(1):53–62. [PubMed] [Google Scholar]
  37. Mehta K., Shahid U., Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J. 1996 Oct;10(12):1408–1417. doi: 10.1096/fasebj.10.12.8903511. [DOI] [PubMed] [Google Scholar]
  38. Morra M., Zubiaur M., Terhorst C., Sancho J., Malavasi F. CD38 is functionally dependent on the TCR/CD3 complex in human T cells. FASEB J. 1998 May;12(7):581–592. doi: 10.1096/fasebj.12.7.581. [DOI] [PubMed] [Google Scholar]
  39. Munshi C. B., Fryxell K. B., Lee H. C., Branton W. D. Large-scale production of human CD38 in yeast by fermentation. Methods Enzymol. 1997;280:318–330. doi: 10.1016/s0076-6879(97)80123-1. [DOI] [PubMed] [Google Scholar]
  40. Nata K., Takamura T., Karasawa T., Kumagai T., Hashioka W., Tohgo A., Yonekura H., Takasawa S., Nakamura S., Okamoto H. Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing. Gene. 1997 Feb 28;186(2):285–292. doi: 10.1016/s0378-1119(96)00723-8. [DOI] [PubMed] [Google Scholar]
  41. Oliver A. M., Martin F., Kearney J. F. Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J Immunol. 1997 Feb 1;158(3):1108–1115. [PubMed] [Google Scholar]
  42. Pegoraro L., Matera L., Ritz J., Levis A., Palumbo A., Biagini G. Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst. 1983 Mar;70(3):447–453. [PubMed] [Google Scholar]
  43. Pelchen-Matthews A., Parsons I. J., Marsh M. Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. J Exp Med. 1993 Oct 1;178(4):1209–1222. doi: 10.1084/jem.178.4.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Peruzzi L., Melioli G., De Monte L. B., Alessio M., Zaccolo M., Roggero S., Bellone G., Funaro A., Malavasi F. Microplate selection technique (MPST). A new method for selecting mouse transfectants expressing human gene products. J Immunol Methods. 1989 Sep 29;123(1):113–121. doi: 10.1016/0022-1759(89)90035-5. [DOI] [PubMed] [Google Scholar]
  45. Santos-Argumedo L., Lund F. E., Heath A. W., Solvason N., Wu W. W., Grimaldi J. C., Parkhouse R. M., Howard M. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Int Immunol. 1995 Feb;7(2):163–170. doi: 10.1093/intimm/7.2.163. [DOI] [PubMed] [Google Scholar]
  46. Spagnoli G. C., Ausiello C. M., Cassone A., Casciani C. U., Bellone G., Malavasi F. Inhibitory effects of anti-HLA-A, B, C heavy chain and anti-beta 2 microglobulin monoclonal antibodies on alloantigen and microbial antigen-induced immune responses in vitro. Scand J Immunol. 1987 Jun;25(6):555–565. doi: 10.1111/j.1365-3083.1987.tb01081.x. [DOI] [PubMed] [Google Scholar]
  47. Stashenko P., Nadler L. M., Hardy R., Schlossman S. F. Expression of cell surface markers after human B lymphocyte activation. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3848–3852. doi: 10.1073/pnas.78.6.3848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. States D. J., Walseth T. F., Lee H. C. Similarities in amino acid sequences of Aplysia ADP-ribosyl cyclase and human lymphocyte antigen CD38. Trends Biochem Sci. 1992 Dec;17(12):495–495. doi: 10.1016/0968-0004(92)90337-9. [DOI] [PubMed] [Google Scholar]
  49. Thomas J. D., Sideras P., Smith C. I., Vorechovský I., Chapman V., Paul W. E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 1993 Jul 16;261(5119):355–358. doi: 10.1126/science.8332900. [DOI] [PubMed] [Google Scholar]
  50. Umar S., Malavasi F., Mehta K. Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties. J Biol Chem. 1996 Jul 5;271(27):15922–15927. doi: 10.1074/jbc.271.27.15922. [DOI] [PubMed] [Google Scholar]
  51. Vorechovsky I., Zhou J. N., Hammarström L., Smith C. I., Thomas J. D., Paul W. E., Notarangelo L. D., Bernatowska-Matuszkiewicz E. Absence of xid mutation in X-linked agammaglobulinaemia. Lancet. 1993 Aug 28;342(8870):552–552. doi: 10.1016/0140-6736(93)91676-d. [DOI] [PubMed] [Google Scholar]
  52. Wang T. F., Guidotti G. CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J Biol Chem. 1996 Apr 26;271(17):9898–9901. [PubMed] [Google Scholar]
  53. Yamashita Y., Miyake K., Kikuchi Y., Takatsu K., Noda S., Kosugi A., Kimoto M. A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells. Immunology. 1995 Jun;85(2):248–255. [PMC free article] [PubMed] [Google Scholar]
  54. Yasue T., Nishizumi H., Aizawa S., Yamamoto T., Miyake K., Mizoguchi C., Uehara S., Kikuchi Y., Takatsu K. A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10307–10312. doi: 10.1073/pnas.94.19.10307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Yel L., Minegishi Y., Coustan-Smith E., Buckley R. H., Trübel H., Pachman L. M., Kitchingman G. R., Campana D., Rohrer J., Conley M. E. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med. 1996 Nov 14;335(20):1486–1493. doi: 10.1056/NEJM199611143352003. [DOI] [PubMed] [Google Scholar]
  56. Zocchi E., Franco L., Guida L., Calder L., De Flora A. Self-aggregation of purified and membrane-bound erythrocyte CD38 induces extensive decrease of its ADP-ribosyl cyclase activity. FEBS Lett. 1995 Feb 6;359(1):35–40. doi: 10.1016/0014-5793(95)00005-t. [DOI] [PubMed] [Google Scholar]
  57. Zupo S., Rugari E., Dono M., Taborelli G., Malavasi F., Ferrarini M. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. Eur J Immunol. 1994 May;24(5):1218–1222. doi: 10.1002/eji.1830240532. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES